Business Standard

Wockhardt likely to sell India business to cut debt, focus on UK: Analysts

Company left with low-margin brands in India after selling profitable ones


Sohini Das Mumbai
Wockhardt, the international pharmaceuticals company, is likely to focus on its UK operations and sell the low-margin India business to pare debt, analysts have said.

Two Mumbai-based analysts told 'Business Standard' that Wockhardt had few options besides selling its Rs 670-crore domestic business. “This is the only business vertical that it can sell, and can fetch about 3-4 times the revenue multiple easily. Many players are looking for brand acquisitions if they come at a reasonable price,” said one analyst, adding that Wockhardt’s next step would be to focus on its UK and EU businesses.

Another analyst said the company

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 21 2022 | 3:26 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to